2 most recent filings and news items mentioning PLSE. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/PLSE/news?limit=20"
Pull PLSE filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayPulse Biosciences reports enrollment is ahead of schedule in its NANOPULSE-AF pivotal study, driven by investigator enthusiasm and an intuitive workflow. This could positively impact the company's chances of regulatory approval.
View filing at SEC.gov →Pulse Biosciences intends to redeem its remaining common stock warrants issued in July 2024, with an exercise deadline of July 13, 2026 at $11.00 per share or redemption at $0.01 per warrant. The company has already raised $123.7 million from its rights offering and warrant redem
View filing at SEC.gov →